<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-167481</identifier>
<setSpec>1131-3587</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Smoking and non-coronary arterial disease. Interventions for promoting smoking cessation</dc:title>
<dc:description xml:lang="en">Smoking is addictive and smokers who have stopped frequently return to the habit. It is the principal preventable cause of death worldwide and one of the main risk factors for the development of both coronary and non-coronary atherosclerotic vascular disease. Cardiologists have been very careful about controlling other cardiovascular risk factors such as diabetes mellitus, dyslipidemia and hypertension, but have been less concerned about promoting smoke cessation. We should, therefore, make a much greater effort to reduce tobacco consumption among our patients. This article contains a review of the relationship between smoking and vascular disease and, based on our own experience, we describe the fundamentals of how we approach and treat tobacco addiction, while highlighting the real potential we have to help at least one-third of our patients to break the habit (AU)</dc:description>
<dc:creator>Morillas Bueno, Miren</dc:creator>
<dc:creator>Umaran Sánchez, Juana</dc:creator>
<dc:creator>Lekuona Goya, Iñaki</dc:creator>
<dc:creator>Salcedo Arruti, Alberto</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El tabaquismo es una enfermedad adictiva crónica con frecuentes recidivas y la primera causa de muerte evitable en el mundo. Es uno de los principales factores de riesgo de enfermedad vascular aterosclerótica coronaria y no coronaria. Los cardiólogos hemos sido muy sensibles al control de otros factores de riesgo cardiovascular como la diabetes mellitus, la hipertensión arterial y la dislipemia, pero nos hemos preocupado poco del tratamiento del hábito tabáquico. Por lo tanto, debemos esforzarnos mucho más para conseguir una reducción del consumo de tabaco en nuestros pacientes. En esta revisión analizamos la relación entre tabaco y enfermedad vascular y, con base en nuestra experiencia, describimos las bases del abordaje y el tratamiento del hábito tabáquico, resaltando la capacidad real que tenemos de deshabituar, al menos, a una tercera parte de los pacientes (AU)</dc:description>
<dc:source>Rev. esp. cardiol. Supl. (Ed. impresa);9(supl.D): 39d-48d, 2009. ilus, graf, tab</dc:source>
<dc:identifier>ibc-167481</dc:identifier>
<dc:title xml:lang="es">Tabaco y enfermedad arterial no coronaria. Intervenciones para el abandono del hábito tabáquico</dc:title>
<dc:subject>^d29815^s22083</dc:subject>
<dc:subject>^d53992^s22012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29815^s22045</dc:subject>
<dc:subject>^d23425^s22000</dc:subject>
<dc:subject>^d24584</dc:subject>
<dc:subject>^d23925^s22012</dc:subject>
<dc:subject>^d24811</dc:subject>
<dc:subject>^d34247^s22054</dc:subject>
<dc:subject>^d29897^s22012</dc:subject>
<dc:subject>^d29897^s22067</dc:subject>
<dc:subject>^d9723^s22000</dc:subject>
<dc:subject>^d34247^s22012</dc:subject>
<dc:subject>^d55932^s22000</dc:subject>
<dc:subject>^d30220^s22000</dc:subject>
<dc:type>article</dc:type>
<dc:date>200900</dc:date>
</metadata>
</record>
</ibecs-document>
